FRANCHINA, Tindara
FRANCHINA, Tindara
Dipartimento di Patologia Umana dell'adulto e dell'età evolutiva "Gaetano Barresi"
A decade of EGFR inhibition in EGFR-mutated non small cell lung cancer (NSCLC): old successes and future perspectives
2015-01-01 Russo, Alessandro; Franchina, Tindara; Ricciardi, Giuseppina Rosaria; Picone, Antonio; Ferraro, Giuseppa; Zanghì, Mariangela; Toscano, Giuseppe; Giordano, Antonio; Adamo, Vincenzo
A new method for titration of oral transmucosal fentanyl citrate (OTFC) starting dose in cancer patients.
2006-01-01 Scandurra, G; Ferraro, Giuseppa; Franchina, Tindara; Chiofalo, G; Zanghi', Mariangela; Festa, V; Pastura, G; Adamo, Vincenzo
Activity and safety of gefitinib and erlotinib in metastatic non-small cell lung cancer (NSCLC): A comparative analysis.
2010-01-01 Franchina, Tindara; Adamo, Barbara; Caristi, Nicola; G., Chiofalo; G., Toscano; Colonese, Francesca; Denaro, Nerina; Ricciardi, GIUSEPPINA ROSARIA; A., Russo; Adamo, Vincenzo; University, Polyclinic; Messina, Italy; School of, Medicine; University, Polyclinic; Palermo, Italy
Activity of pegylated liposomal doxorubicin in combination with gemcitabine in triple negative breast cancer with skin involvement: Two case reports.
2012-01-01 Franchina, Tindara; Adamo, Barbara; Ricciardi, GIUSEPPINA ROSARIA; Caristi, Nicola; Agostino, RITA MARIA; Proto, Claudia; Adamo, Vincenzo
Adverse Drug Reactions with HER2-Positive Breast Cancer Treatment: An Analysis from the Italian Pharmacovigilance Database
2021-01-01 Barbieri, M. A.; Sorbara, E. E.; Cicala, G.; Santoro, V.; Cutroneo, P. M.; Franchina, T.; Spina, E.
Androgen Receptor (AR), E-Cadherin, and Ki-67 as emerging targets and novel prognostic markers in triple-negative breast cancer (TNBC) patients
2015-01-01 Ricciardi, GIUSEPPINA ROSARIA; Adamo, Barbara; Ieni, Antonio; Licata, Luana; Cardia, Roberta; Ferraro, Giuseppa; Franchina, Tindara; Tuccari, Giovanni; Adamo, Vincenzo
Androgen receptor (AR), E-cadherin, and Ki-67 as prognostic markers in triple-negative breast cancer (TNBC).
2013-01-01 Ricciardi, GIUSEPPINA ROSARIA; Adamo, Barbara; Ferraro, Giuseppa; Franchina, Tindara; Zanghi', Mariangela; Buda, Carmelo; Trimarchi, Giuseppe; Cardia, R; Tuccari, Giovanni; Adamo, Vincenzo
Author Correction to: Prevalence of Use and Cost of Biological Drugs for Cancer Treatment: A 5-Year Picture from Southern Italy
2017-01-01 Lucchesi, Simona; Marciano', Ilaria; Paolo, Panagia; Intelisano, Rosanna; Maria Pia Randazzo, ; Sgroi, Carmela; Altavilla, Giuseppe; Santarpia, Mariacarmela; Adamo, Vincenzo; Franchina, Tindara; Francesco, Ferraù; Paolina, Reitano; Trifiro', Gianluca
Baseline neutrophilia, derived neutrophil-to-lymphocyte ratio (dNLR), platelet-to-lymphocyte ratio (PLR), and outcome in non small cell lung cancer (NSCLC) treated with Nivolumab or Docetaxel
2018-01-01 Russo, A.; Franchina, T.; Ricciardi, G. R. R.; Battaglia, A.; Scimone, A.; Berenato, R.; Giordano, A.; Adamo, V.
Brain metastases in patients with non-small cell lung cancer: focus on the role of chemotherapy.
2006-01-01 Adamo, Vincenzo; Franchina, Tindara; Adamo, Barbara; Scandurra, G; Scimone, Andrea
Can we better manage advanced NSCLC in the elderly with the new therapeutic agents? Preliminary analysis of a real life multicenter study.
2017-01-01 Franchina, T; Novello, S; Russo, A; Gianetta, M; Capelletto, E; Galetta, D; Catino, A; Migliorino, Mr; Ricciardi, S; Morgillo, F; Della Corte, Cm; Rocco, D; Soto Parra, Hj; Russo, A; Ambrosio, F; Franchina, V; Adamo, V
Central nervous system involvement in ALK-rearranged NSCLC: promising strategies to overcome crizotinib resistance
2016-01-01 Russo, Alessandro; Franchina, Tindara; Ricciardi, Giuseppina Rosaria Rita; Ferraro, Giuseppa; Scimone, Antonino; Bronte, Giuseppe; Russo, Antonio; Rolfo, Christian; Adamo, Vincenzo
Challenges and promises of physical exercise in advances lung cancer patients
2018-01-01 Franchina, T.; Russo, A.; Ricciardi, G. R. R.; Righi, M.; Franchina, V.; Adamo, V.; Magaudda, L.
Circulating miR-22, miR-24 and miR-34a as novel predictive biomarkers to pemetrexed-based chemotherapy in advanced non small cell lung cancer.
2014-01-01 Franchina T; Amodeo V; Bronte G; Savio G; Ricciardi GR; Picciotto M; Russo A; Giordano A; Adamo V.
Clinical significance of circulating interleukin-23 as a prognostic factor in breast cancer patients.
2012-01-01 Gangemi, Sebastiano; Minciullo, PAOLA LUCIA; Adamo, Barbara; Franchina, Tindara; Ricciardi, GIUSEPPINA ROSARIA; Ferraro, M; Briguglio, Roberta; Toscano, G; Saitta, Salvatore; Adamo, Vincenzo
Correction: Androgen Receptor (AR), E-cadherin, and Ki-67 as emerging targets and novel prognostic markers in Triple-Negative Breast Cancer (TNBC) patients
2015-01-01 Ricciardi, Giuseppina Rosaria Rita; Adamo, Barbara; Ieni, Antonio; Licata, Luana; Cardia, Roberta; Ferraro, Giuseppa; Franchina, Tindara; Tuccari, Giovanni; Adamo, Vincenzo
Corticosteroids in oncology: Use, overuse, indications, contraindications. An Italian Association of Medical Oncology (AIOM)/ Italian Association of Medical Diabetologists (AMD)/ Italian Society of Endocrinology (SIE)/ Italian Society of Pharmacology (SIF) multidisciplinary consensus position paper
2022-01-01 Faggiano, A.; Mazzilli, R.; Natalicchio, A.; Adinolfi, V.; Argentiero, A.; Danesi, R.; D'Oronzo, S.; Fogli, S.; Gallo, M.; Giuffrida, D.; Gori, S.; Montagnani, M.; Ragni, A.; Renzelli, V.; Russo, A.; Silvestris, N.; Franchina, T.; Tuveri, E.; Cinieri, S.; Colao, A.; Giorgino, F.; Zatelli, M. C.
Diagnosis and treatment of early and locally advanced non-small-cell lung cancer: The 2019 AIOM (Italian Association of Medical Oncology) clinical practice guidelines
2020-01-01 Passiglia, F.; Bertolaccini, L.; Del Re, M.; Facchinetti, F.; Ferrara, R.; Franchina, T.; Malapelle, U.; Menis, J.; Passaro, A.; Pilotto, S.; Ramella, S.; Rossi, G.; Trisolini, R.; Novello, S.
Efficacy of nab-paclitaxel plus trastuzumab in a long-surviving heavily pretreated HER2-positive breast cancer patient with brain metastases
2015-01-01 Ricciardi, Giuseppina Rosaria Rita; Russo, Alessandro; Franchina, Tindara; Ferraro, Giuseppa; Adamo, Vincenzo
Efficacy of T-DM1 for leptomeningeal and brain metastases in a HER2 positive metastatic breast cancer patient: New directions for systemic therapy - a case report and literature review
2018-01-01 Ricciardi, Giuseppina Rosaria Rita; Russo, Alessandro; Franchina, Tindara; Schifano, Silvia; Mastroeni, Giampiero; Santacaterina, Anna; Adamo, Vincenzo
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| A decade of EGFR inhibition in EGFR-mutated non small cell lung cancer (NSCLC): old successes and future perspectives | 1-gen-2015 | Russo, Alessandro; Franchina, Tindara; Ricciardi, Giuseppina Rosaria; Picone, Antonio; Ferraro, Giuseppa; Zanghì, Mariangela; Toscano, Giuseppe; Giordano, Antonio; Adamo, Vincenzo | |
| A new method for titration of oral transmucosal fentanyl citrate (OTFC) starting dose in cancer patients. | 1-gen-2006 | Scandurra, G; Ferraro, Giuseppa; Franchina, Tindara; Chiofalo, G; Zanghi', Mariangela; Festa, V; Pastura, G; Adamo, Vincenzo | |
| Activity and safety of gefitinib and erlotinib in metastatic non-small cell lung cancer (NSCLC): A comparative analysis. | 1-gen-2010 | Franchina, Tindara; Adamo, Barbara; Caristi, Nicola; G., Chiofalo; G., Toscano; Colonese, Francesca; Denaro, Nerina; Ricciardi, GIUSEPPINA ROSARIA; A., Russo; Adamo, Vincenzo; University, Polyclinic; Messina, Italy; School of, Medicine; University, Polyclinic; Palermo, Italy | |
| Activity of pegylated liposomal doxorubicin in combination with gemcitabine in triple negative breast cancer with skin involvement: Two case reports. | 1-gen-2012 | Franchina, Tindara; Adamo, Barbara; Ricciardi, GIUSEPPINA ROSARIA; Caristi, Nicola; Agostino, RITA MARIA; Proto, Claudia; Adamo, Vincenzo | |
| Adverse Drug Reactions with HER2-Positive Breast Cancer Treatment: An Analysis from the Italian Pharmacovigilance Database | 1-gen-2021 | Barbieri, M. A.; Sorbara, E. E.; Cicala, G.; Santoro, V.; Cutroneo, P. M.; Franchina, T.; Spina, E. | |
| Androgen Receptor (AR), E-Cadherin, and Ki-67 as emerging targets and novel prognostic markers in triple-negative breast cancer (TNBC) patients | 1-gen-2015 | Ricciardi, GIUSEPPINA ROSARIA; Adamo, Barbara; Ieni, Antonio; Licata, Luana; Cardia, Roberta; Ferraro, Giuseppa; Franchina, Tindara; Tuccari, Giovanni; Adamo, Vincenzo | |
| Androgen receptor (AR), E-cadherin, and Ki-67 as prognostic markers in triple-negative breast cancer (TNBC). | 1-gen-2013 | Ricciardi, GIUSEPPINA ROSARIA; Adamo, Barbara; Ferraro, Giuseppa; Franchina, Tindara; Zanghi', Mariangela; Buda, Carmelo; Trimarchi, Giuseppe; Cardia, R; Tuccari, Giovanni; Adamo, Vincenzo | |
| Author Correction to: Prevalence of Use and Cost of Biological Drugs for Cancer Treatment: A 5-Year Picture from Southern Italy | 1-gen-2017 | Lucchesi, Simona; Marciano', Ilaria; Paolo, Panagia; Intelisano, Rosanna; Maria Pia Randazzo, ; Sgroi, Carmela; Altavilla, Giuseppe; Santarpia, Mariacarmela; Adamo, Vincenzo; Franchina, Tindara; Francesco, Ferraù; Paolina, Reitano; Trifiro', Gianluca | |
| Baseline neutrophilia, derived neutrophil-to-lymphocyte ratio (dNLR), platelet-to-lymphocyte ratio (PLR), and outcome in non small cell lung cancer (NSCLC) treated with Nivolumab or Docetaxel | 1-gen-2018 | Russo, A.; Franchina, T.; Ricciardi, G. R. R.; Battaglia, A.; Scimone, A.; Berenato, R.; Giordano, A.; Adamo, V. | |
| Brain metastases in patients with non-small cell lung cancer: focus on the role of chemotherapy. | 1-gen-2006 | Adamo, Vincenzo; Franchina, Tindara; Adamo, Barbara; Scandurra, G; Scimone, Andrea | |
| Can we better manage advanced NSCLC in the elderly with the new therapeutic agents? Preliminary analysis of a real life multicenter study. | 1-gen-2017 | Franchina, T; Novello, S; Russo, A; Gianetta, M; Capelletto, E; Galetta, D; Catino, A; Migliorino, Mr; Ricciardi, S; Morgillo, F; Della Corte, Cm; Rocco, D; Soto Parra, Hj; Russo, A; Ambrosio, F; Franchina, V; Adamo, V | |
| Central nervous system involvement in ALK-rearranged NSCLC: promising strategies to overcome crizotinib resistance | 1-gen-2016 | Russo, Alessandro; Franchina, Tindara; Ricciardi, Giuseppina Rosaria Rita; Ferraro, Giuseppa; Scimone, Antonino; Bronte, Giuseppe; Russo, Antonio; Rolfo, Christian; Adamo, Vincenzo | |
| Challenges and promises of physical exercise in advances lung cancer patients | 1-gen-2018 | Franchina, T.; Russo, A.; Ricciardi, G. R. R.; Righi, M.; Franchina, V.; Adamo, V.; Magaudda, L. | |
| Circulating miR-22, miR-24 and miR-34a as novel predictive biomarkers to pemetrexed-based chemotherapy in advanced non small cell lung cancer. | 1-gen-2014 | Franchina T; Amodeo V; Bronte G; Savio G; Ricciardi GR; Picciotto M; Russo A; Giordano A; Adamo V. | |
| Clinical significance of circulating interleukin-23 as a prognostic factor in breast cancer patients. | 1-gen-2012 | Gangemi, Sebastiano; Minciullo, PAOLA LUCIA; Adamo, Barbara; Franchina, Tindara; Ricciardi, GIUSEPPINA ROSARIA; Ferraro, M; Briguglio, Roberta; Toscano, G; Saitta, Salvatore; Adamo, Vincenzo | |
| Correction: Androgen Receptor (AR), E-cadherin, and Ki-67 as emerging targets and novel prognostic markers in Triple-Negative Breast Cancer (TNBC) patients | 1-gen-2015 | Ricciardi, Giuseppina Rosaria Rita; Adamo, Barbara; Ieni, Antonio; Licata, Luana; Cardia, Roberta; Ferraro, Giuseppa; Franchina, Tindara; Tuccari, Giovanni; Adamo, Vincenzo | |
| Corticosteroids in oncology: Use, overuse, indications, contraindications. An Italian Association of Medical Oncology (AIOM)/ Italian Association of Medical Diabetologists (AMD)/ Italian Society of Endocrinology (SIE)/ Italian Society of Pharmacology (SIF) multidisciplinary consensus position paper | 1-gen-2022 | Faggiano, A.; Mazzilli, R.; Natalicchio, A.; Adinolfi, V.; Argentiero, A.; Danesi, R.; D'Oronzo, S.; Fogli, S.; Gallo, M.; Giuffrida, D.; Gori, S.; Montagnani, M.; Ragni, A.; Renzelli, V.; Russo, A.; Silvestris, N.; Franchina, T.; Tuveri, E.; Cinieri, S.; Colao, A.; Giorgino, F.; Zatelli, M. C. | |
| Diagnosis and treatment of early and locally advanced non-small-cell lung cancer: The 2019 AIOM (Italian Association of Medical Oncology) clinical practice guidelines | 1-gen-2020 | Passiglia, F.; Bertolaccini, L.; Del Re, M.; Facchinetti, F.; Ferrara, R.; Franchina, T.; Malapelle, U.; Menis, J.; Passaro, A.; Pilotto, S.; Ramella, S.; Rossi, G.; Trisolini, R.; Novello, S. | |
| Efficacy of nab-paclitaxel plus trastuzumab in a long-surviving heavily pretreated HER2-positive breast cancer patient with brain metastases | 1-gen-2015 | Ricciardi, Giuseppina Rosaria Rita; Russo, Alessandro; Franchina, Tindara; Ferraro, Giuseppa; Adamo, Vincenzo | |
| Efficacy of T-DM1 for leptomeningeal and brain metastases in a HER2 positive metastatic breast cancer patient: New directions for systemic therapy - a case report and literature review | 1-gen-2018 | Ricciardi, Giuseppina Rosaria Rita; Russo, Alessandro; Franchina, Tindara; Schifano, Silvia; Mastroeni, Giampiero; Santacaterina, Anna; Adamo, Vincenzo |